Bio-Rad Laboratories (BIO) News Today $249.14 +0.29 (+0.12%) As of 02:05 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Teachers Retirement System of The State of Kentucky Cuts Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Teachers Retirement System of The State of Kentucky trimmed its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 6.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investoApril 24 at 6:02 AM | marketbeat.comDimensional Fund Advisors LP Grows Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)Dimensional Fund Advisors LP boosted its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 14.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 746,119 shares of the medical research company's stock after buying an additionalApril 24 at 5:02 AM | marketbeat.comInvesco Ltd. Has $12.79 Million Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)Invesco Ltd. trimmed its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 3.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 38,944 shares of the medical research company's stock afteApril 23 at 3:41 AM | marketbeat.comDoes Bio-Rad Laboratories (BIO) Offer a Solid Financial Profile?April 22 at 9:10 AM | insidermonkey.comBarclays PLC Sells 1,557 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Barclays PLC lowered its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 3.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 40,419 shares of the medical research company's stock after sellingApril 22 at 3:57 AM | marketbeat.comShould You be Optimistic on Bio-Rad Laboratories’s (BIO) Outlook?April 21 at 9:58 AM | insidermonkey.comXTX Topco Ltd Buys New Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)XTX Topco Ltd purchased a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 1,949 shares of the medical research company's stock, valued at approximatelApril 21 at 4:50 AM | marketbeat.comRussell Investments Group Ltd. Sells 3,427 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Russell Investments Group Ltd. lowered its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 36.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,102 shares of the mApril 21 at 3:44 AM | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Short Interest UpdateBio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) was the recipient of a large decline in short interest in March. As of March 31st, there was short interest totalling 710,400 shares, a decline of 29.0% from the March 15th total of 1,000,000 shares. Based on an average trading volume of 323,400 shares, the short-interest ratio is presently 2.2 days. Currently, 3.7% of the company's stock are sold short.April 20, 2025 | marketbeat.comBrant Point Investment Management LLC Acquires Shares of 12,500 Bio-Rad Laboratories, Inc. (NYSE:BIO)Brant Point Investment Management LLC bought a new stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm bought 12,500 shares of the medical research company's stock, valued at approximatApril 20, 2025 | marketbeat.comWells Fargo & Company Lowers Bio-Rad Laboratories (NYSE:BIO) Price Target to $270.00Wells Fargo & Company reduced their target price on shares of Bio-Rad Laboratories from $320.00 to $270.00 and set an "equal weight" rating on the stock in a research report on Thursday.April 19, 2025 | marketbeat.comOntario Teachers Pension Plan Board Makes New Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO)Ontario Teachers Pension Plan Board acquired a new stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 2,038 shares of the medical research company's stock, valued aApril 19, 2025 | marketbeat.comWells Fargo & Company Cuts Bio-Rad Laboratories (NYSE:BIO) Price Target to $270.00April 19, 2025 | americanbankingnews.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Acquired by LPL Financial LLCLPL Financial LLC boosted its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 34.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,195 shares of the medical research company's stock after acquiring an additional 1,326 sharesApril 19, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Bought by Portolan Capital Management LLCPortolan Capital Management LLC lifted its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 39.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 30,586 shares of the medical research company's stock aApril 16, 2025 | marketbeat.comLegal & General Group Plc Lowers Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Legal & General Group Plc lessened its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 38.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 58,932 shares of the medical researchApril 16, 2025 | marketbeat.comWellington Management Group LLP Has $266,000 Stock Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Wellington Management Group LLP cut its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 91.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 810 shares of the medical reseaApril 16, 2025 | marketbeat.comBrokerages Set Bio-Rad Laboratories, Inc. (NYSE:BIO) Target Price at $395.20April 16, 2025 | americanbankingnews.comEnvestnet Asset Management Inc. Boosts Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Envestnet Asset Management Inc. raised its position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 6.4% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 105,027 shares of the medical research company's stock after acquiring anApril 14, 2025 | marketbeat.comJPMorgan Chase & Co. Has $15.49 Million Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)JPMorgan Chase & Co. decreased its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 12.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 47,148 shares of theApril 14, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Receives Consensus Recommendation of "Moderate Buy" from AnalystsShares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) have been assigned an average rating of "Moderate Buy" from the five research firms that are covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating and three have assignedApril 14, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Acquired by CenterBook Partners LPCenterBook Partners LP boosted its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 182.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 11,819 shares of the medical research company's sApril 12, 2025 | marketbeat.comResona Asset Management Co. Ltd. Buys New Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)Resona Asset Management Co. Ltd. bought a new stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 5,610 shares of the medical research cApril 12, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Geode Capital Management LLCGeode Capital Management LLC lessened its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 0.6% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 321,977 shares of the medical research company's stock after selling 1,931 shares during the period. GeApril 12, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Massachusetts Financial Services Co. MAMassachusetts Financial Services Co. MA lowered its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 93.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,597 shares of the medApril 11, 2025 | marketbeat.comFederated Hermes Inc. Increases Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)Federated Hermes Inc. boosted its position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 13.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 137,561 shares of the medicApril 10, 2025 | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Reaches New 12-Month Low - What's Next?Bio-Rad Laboratories (NYSE:BIO) Hits New 1-Year Low - Should You Sell?April 9, 2025 | marketbeat.comGrantham Mayo Van Otterloo & Co. LLC Sells 40,015 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Grantham Mayo Van Otterloo & Co. LLC lessened its position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 48.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 42,784 shares of the medical research company's stock afApril 8, 2025 | marketbeat.comExodusPoint Capital Management LP Buys Shares of 15,807 Bio-Rad Laboratories, Inc. (NYSE:BIO)ExodusPoint Capital Management LP purchased a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 15,807 shares of the medical reseApril 8, 2025 | marketbeat.comFranklin Resources Inc. Has $44.37 Million Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)Franklin Resources Inc. increased its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 15.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 135,057 shares of the medical research company's stApril 7, 2025 | marketbeat.comArrowstreet Capital Limited Partnership Boosts Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)Arrowstreet Capital Limited Partnership lifted its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 409.8% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 36,956 shares of the medical research company's stock after purchasing an additional 29,7April 7, 2025 | marketbeat.comBryce Point Capital LLC Purchases Shares of 1,597 Bio-Rad Laboratories, Inc. (NYSE:BIO)Bryce Point Capital LLC acquired a new position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,597 shares of the medical research companyApril 6, 2025 | marketbeat.comNorges Bank Invests $41.64 Million in Bio-Rad Laboratories, Inc. (NYSE:BIO)Norges Bank bought a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 126,766 shares of the medical research company's stock,April 6, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Acquired by Prudential Financial Inc.Prudential Financial Inc. lifted its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 173.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,968 shares ofApril 6, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by CIBC Private Wealth Group LLCCIBC Private Wealth Group LLC lowered its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 2.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 42,106 shares of the medical research company's stoApril 2, 2025 | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Reaches New 1-Year Low - Here's WhyBio-Rad Laboratories (NYSE:BIO) Reaches New 12-Month Low - Here's What HappenedApril 2, 2025 | marketbeat.comMitsubishi UFJ Trust & Banking Corp Has $2.68 Million Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)Mitsubishi UFJ Trust & Banking Corp decreased its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 14.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 8,161 shares of the medical research company'sApril 2, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Bought by Vanguard Group Inc.Vanguard Group Inc. grew its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 0.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,919,808 shares of the medical research company's stock after acquiriApril 1, 2025 | marketbeat.comMawer Investment Management Ltd. Grows Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)Mawer Investment Management Ltd. lifted its position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 17.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 256,927 shares of the medical research company's stock after purchasiMarch 31, 2025 | marketbeat.comKLP Kapitalforvaltning AS Purchases New Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)KLP Kapitalforvaltning AS purchased a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 7,100 shares of the medical research company's stock, valued at approxiMarch 29, 2025 | marketbeat.comBio-Rad Laboratories (BIO) Receives a Hold from JefferiesMarch 29, 2025 | markets.businessinsider.comBio-Rad Laboratories (NYSE:BIO) Hits New 12-Month Low - Here's WhyBio-Rad Laboratories (NYSE:BIO) Hits New 1-Year Low - Should You Sell?March 27, 2025 | marketbeat.comBIO-key Trims 2024 Net Loss 49% to $4.3M, Reflecting Higher Gross Margin and Lower Operating Costs, Offsetting 11% Revenue Decrease Due to Business Transition; Hosts Investor Call Today at 10am ETMarch 27, 2025 | globenewswire.com15,581 Shares in Bio-Rad Laboratories, Inc. (NYSE:BIO) Purchased by Raymond James Financial Inc.Raymond James Financial Inc. bought a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 15,581 shares of the medical researchMarch 26, 2025 | marketbeat.comFox Run Management L.L.C. Buys New Shares in Bio-Rad Laboratories, Inc. (NYSE:BIO)Fox Run Management L.L.C. bought a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 3,122 shares of the medical research company's stMarch 24, 2025 | marketbeat.comSei Investments Co. Acquires 18,873 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Sei Investments Co. boosted its holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 7.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 271,387 shares of the medical research company's stock afMarch 24, 2025 | marketbeat.comNatixis Advisors LLC Buys 4,390 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Natixis Advisors LLC grew its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 10.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 45,713 shares of the medical research company's stock afMarch 19, 2025 | marketbeat.comSwiss National Bank Cuts Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Swiss National Bank lessened its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 7.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 54,700 shares of the medical research cMarch 19, 2025 | marketbeat.comAvantax Advisory Services Inc. Sells 1,365 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Avantax Advisory Services Inc. trimmed its position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 23.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 4,336 shares of the medical research company's stock afterMarch 19, 2025 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Receives Average Recommendation of "Moderate Buy" from BrokeragesBio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) has been given a consensus rating of "Moderate Buy" by the five ratings firms that are currently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and three have given a buy recMarch 19, 2025 | marketbeat.com Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Email Address BIO Media Mentions By Week BIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIO News Sentiment▼1.270.72▲Average Medical News Sentiment BIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIO Articles This Week▼156▲BIO Articles Average Week Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Mettler-Toledo International News Waters News Illumina News Bio-Techne News Bruker News Charles River Laboratories International News Pacific Biosciences of California News Harvard Bioscience News Thermo Fisher Scientific News Agilent Technologies News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BIO) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredTrump’s treachery Intuitive Surgical at $1.99. Nvidia at $11. Shorting Fannie Mae months before collapse. That’s this analyst’s ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BIO Stock Free BIO Stock Alerts